BioVie

BioVie

United States
BioVie is pioneering an innovative therapeutic approach targeting ascites due to liver cirrhosis. Ascites, or the accumulation of fluid in the abdomen, is the most common complication of cirrhosis due to NASH (non-alcoholic steatohepatitis), alcoholic liver disease and/or hepatitis C. Ascites affects about 100,000 Americans and many times more worldwide, and contributes substantially to mortality. Our therapy BIV201 is based on a drug that is not yet available in the US but is approved in about 50 countries to treat related complications of liver cirrhosis. The Company, formerly knows as NanoAntibiotics, Inc., recently acquired LAT Pharma LLC. This merger provided our lead development program, BIV201. Following a pre-investigational new drug meeting (“pre-IND”) with the FDA in early 2016, the Company is now assembling its IND package, and may commence a US clinical trial as early as 2017.
Founded date
01/01/2013
# of employees
11-50
Company type
For Profit

General & financials

Estimated revenue
$10M to $50M
# of funders
1
Founders
Cuong Do
Industry group
Biotechnology, Health Care, Professional Services, Science and Engineering

Founding

Top 5 investors
Avenue Capital Group
# of funding runds
4
Last founding
$15.000.000
Total funded
$47.500.000

See more companies

See full list
thinktank.net

thinktank.net

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
Amethyst Radiotherapy

Amethyst Radiotherapy

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
Refocus Group

Refocus Group

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
ZyVersa Therapeutics

ZyVersa Therapeutics

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
AbilTo

AbilTo

Estimated revenue
$1M to $10M
# of employees
101-250
Company type
For Profit
Pythian

Pythian

Estimated revenue
$1M to $10M
# of employees
251-500
Company type
For Profit
Axio Biosolutions

Axio Biosolutions

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Health Hero Network

Health Hero Network

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit

How to get access to the full list?

Duplicate this list

Get access to a comprehensive list of companies with their industries, location and contacts infos.

Prepare outreach

Drafting good emails makes you more likely to get get results.

Track & Follow

Keeping momentum by managing all your angel investors prospects in a pipeline with pre-set stages: "contacted", "replied", "in discussion" for ex. Follow-up tightly, close in time.

What is folk?

folk is a lightweight and easy-to-use CRM that you can leverage to build lists of contacts and manage your processes with these contacts.

How to get access to this list of companies?

You can simply duplicate the list. You will need to create a folk account in order to duplicate the list properly.

What can I do with the list after duplicating it? 

On folk, you can directly email these companies and manage them in a pipeline board.